Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer.
Peruzzi E, Gerratana L, Montico M, Posocco B, Corsetti S, Bartoletti M, Gagno S, Orleni M, De Mattia E, Baraldo M, Cecchin E, Puglisi F, Toffoli G, Roncato R.
Peruzzi E, et al. Among authors: corsetti s.
Biomed Pharmacother. 2023 Nov;167:115479. doi: 10.1016/j.biopha.2023.115479. Epub 2023 Sep 19.
Biomed Pharmacother. 2023.
PMID: 37734262
Free article.